by CN Bio. | Apr 26, 2022 | NASH, Press releases
First product within new ‘in-a-box’ range, which harnesses next-generation, human-relevant Liver-on-a-Chip technology to improve the accuracy and efficiency of NASH drug discovery Cambridge, UK, 26 April 2022: CN Bio, a leading Organ-on-a-chip Company (OOC) that...
by CN Bio. | Mar 23, 2022 | Blog
The human lung is in crisis Our lungs represent the only internal organ that is directly subject to the environment and therefore face a relentless battle against foreign matter. For centuries, they have been assaulted by enemies – both natural and synthetic....
by CN Bio. | Feb 24, 2022 | Uncategorised
Organ-on-a-chip (OOC) technology offers you a transformative approach to better science. By bridging the gaps between traditional cell culture, animal models and the clinic, its complementary use offers the promise of deeper, human-relevant insights and more informed...
by CN Bio. | Dec 7, 2021 | Blog, OOC Blog
The liver is responsible for metabolizing most medications, and as such represents one of the primary tissues affected by adverse drug reactions. Drug-induced liver injury (DILI) is a potential complication of nearly all classes of medication. Unfortunately,...
by CN Bio. | Dec 1, 2021 | Press releases
Next generation Organ-on-a-Chip technology listed second in Top 10 Innovations for 2021 System enables pre-clinical studies that simulate complex interaction and communication between organs, such as liver, gut, lung, and kidney, for accelerated drug discovery and...
